This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Domenico Agostino, MD; Eugene E. Cliffton, MD

AMA Arch Surg. 1967;94(3):313-315.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

SPLENIC metastases are infrequent clinically and in experimental animals.^1,2 Some investigators have attributed this to the "poor soil" of this organ¹; others to a fibrosing process.³ The peculiarities of the vascular system of the spleen may also account for the infrequency of metastases.² It has been shown in hamsters that lymphosarcoma cells lodge in the spleen, but that cells from carcinoma do not Iodge.⁴ Tumor cells have been demonstrated in the spleen of mice but only when the peritoneum was the source of the tumor or could have been contaminated by extension of the tumor.⁵

In a previous study in our laboratory, a homogenate of individual organs removed four hours after the systemic inoculation of Walker 256 cancer cells was injected subcutaneously into new recipient animals. "Takes" were obtained with lung homogenate in 100% of the animals, kidney 90%, liver 80%, heart 50%, . . . [Full Text PDF of this Article]

Author Affiliations
New York

From the Clotting Mechanisms Section of the Division of Experimental Surgery and Physiology, Sloan-Kettering Institute for Cancer Research and Cornell University Medical College, New York.

Footnotes
Submitted for publication Sept 29, 1966.

Reprint requests to Clotting Mechanisms Section, Sloan-Kettering Institute for Cancer Research, 444 E 68th St, New York 10021 (Dr. Cliffton).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?